Single-Cell Sequencing Screening of Biomarkers Associated with Lipophagy in the MPTP Model Mice of Parkinson's Disease
- PMID: 40537664
- DOI: 10.1007/s12035-025-05014-0
Single-Cell Sequencing Screening of Biomarkers Associated with Lipophagy in the MPTP Model Mice of Parkinson's Disease
Abstract
Lipophagy may play an antioxidant and protective role in the pathogenesis of Parkinson's disease (PD). However, the specific mechanism of lipophagy in PD is rarely reported. MPTP model mice brains (PD, n = 3; CON, n = 3) underwent scRNA-seq. Post-QC, cells were clustered and annotated. Differential infiltrated cells (DICs) were identified between PD and CON. DICs were further sub-clustered. DIC-DEGs and DE-LRGs were determined. Overlapping DIC-DEGs and DE-LRGs yielded candidate genes. CytoNCA's five algorithms screened biomarkers. Biomarker expression was compared between PD and CON. Cell-cell communication and pseudotime analyses explored communication and differentiation. In scRNA-seq, 28 distinct clusters were annotated with seven known cell types, including oligodendrocytes, astrocytes, and neurons. Among them, the DICs, oligodendrocytes, and neurons were clustered into six and seven distinct cell subclusters, respectively. Importantly, a total of 241 DIC-DEGs and 664 DEGs were identified, followed by generating 179 candidate genes. Ubb, Gapdh, Cox4i1, and Hsp90aa1 were determined as biomarkers by five algorithms. Notably, the expression levels of four biomarkers were significantly different in oligodendrocytes and neurons between the PD and CON groups. Subsequently, the pseudotime analysis found that the expression of biomarkers was higher at the end of differentiation in both oligodendrocytes and neurons. What is more, the cell crosstalk between the oligodendrocytes and neurons was high in PD and CON groups. Overall, Ubb, Gapdh, Cox4i1, and Hsp90aa1 were mined as biomarkers, and oligodendrocytes and neurons were key cells in PD patients. Our findings provided new theoretical support for PD treatment.
Keywords: Biomarkers; Lipophagy; Neurons; Oligodendrocytes; Parkinson; Single-cell.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of West China Hospital of Sichuan University (Date.2021.11.20/20211498 A). Consent to Participate: Not applicable. Consent to Publish: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Chen Z, Li G, Liu J (2020) Autonomic dysfunction in Parkinson’s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiology of disease 134:104700. https://doi.org/10.1016/j.nbd.2019.104700 - DOI - PubMed
-
- Stoker TB, Barker RA (2020) Recent developments in the treatment of Parkinson’s disease. F1000Research 9. https://doi.org/10.12688/f1000research.25634.1
-
- Kory N, Farese RV Jr, Walther TC (2016) Targeting Fat: mechanisms of protein localization to lipid droplets. Trends in cell biology 26(7):535–546. https://doi.org/10.1016/j.tcb.2016.02.007 - DOI - PubMed - PMC
-
- Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, Madeo F (2012) FAT SIGNALS–lipases and lipolysis in lipid metabolism and signaling. Cell metabolism 15(3):279–291. https://doi.org/10.1016/j.cmet.2011.12.018 - DOI - PubMed - PMC
-
- Ohsaki Y, Suzuki M, Fujimoto T (2014) Open questions in lipid droplet biology. Chemistry & biology 21(1):86–96. https://doi.org/10.1016/j.chembiol.2013.08.009 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
